January 28, 2014
A total of 237 doctors were invited to participate in the survey. Of those, 104 doctors (44%) chose to do so. The responding doctors had the following organizational affiliations:
Respondents consisted of 80% men and 20% women.
Other features of the responding doctors were as follows:
Distribution of respondents by province:
Types of chronic liver disease treated by the surveyed doctors:
The proportion of physicians who routinely assessed the liver fibrosis of patients by condition was as follows:
The tool most commonly used to assess liver fibrosis was liver biopsy, used by 46% of physicians. This was followed by Fibroscan, used by 39% and Fibrotest, used by 8% of doctors.
The researchers found that overall, the use of non-invasive methods of assessing liver injury reduced the need for liver biopsy by 43%.
Older physicians, hepatologists and infectious disease specialists were more likely to use non-invasive methods than younger doctors. Also, physicians who worked out of a university-based hospital or private practice were more likely to use non-invasive methods.
No comments have been made.
|Really Rapid Review -- AIDS 2016, Durban|
|Update on Genetic Engineering for an HIV Cure|
|Charlize Theron's 8 Quotable Moments About HIV at AIDS 2016|
|This Week in HIV Research: New Protein Could Shock and Kill Latent HIV, and Engineered T Cells Could Help Fight HIV|
|At AIDS 2016, the Global Village Rocks -- and Activists Party Without Pants|